Watts GF - Search Results

1

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.

Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, Bruckert E, Defesche J, Lin KK, Livingston M, Mata P, Parhofer KG, Raal FJ, Santos RD, Sijbrands EJ, Simpson WG, Sullivan DR, Susekov AV, Tomlinson B, Wiegman A, Yamashita S, Kastelein JJ; International Familial Hypercholesterolemia Foundation. Watts GF, et al. Eur J Prev Cardiol. 2015 Jul;22(7):849-54. doi: 10.1177/2047487314533218. Epub 2014 Apr 28. Eur J Prev Cardiol. 2015. PMID: 24776375 Review.

2

Aortic compliance in young patients with heterozygous familial hypercholesterolaemia.

Lehmann ED, Watts GF, Fatemi-Langroudi B, Gosling RG. Lehmann ED, et al. Among authors: watts gf. Clin Sci (Lond). 1992 Dec;83(6):717-21. doi: 10.1042/cs0830717. Clin Sci (Lond). 1992. PMID: 1336443

3

One year experience in the treatment of familial hypercholesterolaemia with simvastatin.

Quiney J, Watts GF, Kerr-Muir M, Slavin B, Lewis B. Quiney J, et al. Among authors: watts gf. Postgrad Med J. 1992 Jul;68(801):575-80. doi: 10.1136/pgmj.68.801.575. Postgrad Med J. 1992. PMID: 1437957 Free PMC article.

4

Simvastatin decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications.

Watts GF, Cummings MH, Umpleby M, Quiney JR, Naoumova R, Thompson GR, Sönksen PH. Watts GF, et al. Eur J Clin Invest. 1995 Aug;25(8):559-67. doi: 10.1111/j.1365-2362.1995.tb01746.x. Eur J Clin Invest. 1995. PMID: 7589011 Clinical Trial.

5

Familial Hypercholesterolaemia Regression Study and its implications.

Watts GF. Watts GF. Lancet. 1995 Apr 1;345(8953):807-8. doi: 10.1016/s0140-6736(95)92958-4. Lancet. 1995. PMID: 7898224 No abstract available.

6

Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia.

Dane-Stewart CA, Watts GF, Mamo JC, Dimmitt SB, Barrett PH, Redgrave TG. Dane-Stewart CA, et al. Among authors: watts gf. Eur J Clin Invest. 2001 Feb;31(2):113-7. doi: 10.1046/j.1365-2362.2001.00785.x. Eur J Clin Invest. 2001. PMID: 11168448

7

Effect of Simvastatin on markers of triglyceride-rich lipoproteins in familial hypercholesterolaemia.

Dane-Stewart CA, Watts GF, Mamo JC, Barrett PH, Martins IJ, Dimmitt SB, Redgrave TG. Dane-Stewart CA, et al. Among authors: watts gf. Eur J Clin Invest. 2002 Jul;32(7):493-9. doi: 10.1046/j.1365-2362.2002.01012.x. Eur J Clin Invest. 2002. PMID: 12153549 Clinical Trial.

8

Cardiovascular risk factors and endothelial dysfunction.

Wierzbicki AS, Chowienczyk PJ, Cockcroft JR, Brett SE, Watts GF, Jenkins BS, Ritter JM. Wierzbicki AS, et al. Among authors: watts gf. Clin Sci (Lond). 2004 Dec;107(6):609-15. doi: 10.1042/CS20040078. Clin Sci (Lond). 2004. PMID: 15450002

9

Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism.

Chan DC, Watts GF, Ng TW, Uchida Y, Sakai N, Yamashita S, Barrett PH. Chan DC, et al. Among authors: watts gf. Clin Chem. 2005 Mar;51(3):578-85. doi: 10.1373/clinchem.2004.045120. Epub 2005 Jan 13. Clin Chem. 2005. PMID: 15650029

10

Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men.

Chan DC, Watts GF, Ng TW, Uchida Y, Sakai N, Yamashita S, Barrett PH. Chan DC, et al. Among authors: watts gf. Clin Biochem. 2005 Sep;38(9):806-12. doi: 10.1016/j.clinbiochem.2005.05.009. Clin Biochem. 2005. PMID: 15992790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

907 results

Search Page

Filters